KASMEJ
Kastamonu Medical Journal

Kastamonu Medical Journal regularly publishes internationally qualified issues in the field of Medicine in the light of up-to-date information.

eISSN: 2757-9336
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Evaluation of anti-spike IgG response after inactivated COVID-19 vaccine in healthcare workers
Abstract
Aim: This study purposed to determine anti-spike IgG levels at the fourth week after the second dose in healthcare workers (HCWs) who had two doses of the CoronaVac vaccine (Sinovac Life Sciences, Beijing, China). The second purpose of the study was to evaluate several factors that may affect antibody levels. Material and Method: The study was performed at Kastamonu Training and Research Hospital. A total of 197 HCWs of both genders aged 20-63 were included in this study. Antibody levels that neutralize the SARS-CoV-2 spike protein S1 subunit were determined using the SARS-CoV-2 IgG II Quant kit from serum samples collected from the subjects between 10-16 March 2021. Also, a questionnaire containing information about demographic and clinical data was administered to all subjects. It was statistically investigated whether these data affected the anti-spike IgG levels. Results: All subjects had anti-spike IgG levels positive. The median value of the subjects' anti-spike IgG levels was calculated as 860.2 AU/mL (Q25: 519.1 AU/mL, Q75: 1674.1 AU/mL). Anti-spike IgG levels were statistically higher in non-smokers and Rh-positive subjects versus the smokers and Rh-negative subjects (p=0.001 and p=0.046, respectively). However, age groups, gender, COVID-19 history, blood type, and seasonal influenza vaccine did not significantly affect anti-spike IgG levels in the subjects (p>0.05). Conclusion: Anti-spike IgG responses were positive in all HCWs who received the CoronaVac vaccine. Besides, the results showed that smoking and Rh-factor affect the anti-spike IgG response. On the other hand, further studies need to examine more parameters with a larger number of subjects.

Keywords : CoronaVac, COVID-19, healthcare worker, SARS-CoV-2 spike protein

Download Article


1. World Health Organization (WHO). Coronavirus disease (COVID-19). Available from: <a href="https://www.who.int/health-topics/">https://www.who.int/health-topics/</a>[Accessed November1, 2022].
2. Australian Government Department of Health and Aged Care. About the COVID-19 pandemic. Available from: <a href="https://www.health.gov.au/health-alerts/covid-19/about">https://www.health.gov.au/health-alerts/covid-19/about</a>[Accessed November1, 2022].
3. Şimşek-Yavuz S, Komsuoğlu&Ccedil;elikyurt FI. An update of anti-viral treatment of COVID-19. Turk J Med Sci 2021;51:3372-90.
4. Pitts PJ. Our most powerful weapon to fight COVID-19: Patient involvement. Patient 2020;13:255.
5. Ndwandwe D, Wiysonge CS. COVID-19 vaccines. CurrOpinImmunol 2021;71:111-6.
6. Heinz FX, Stiasny K. Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action. NPJ Vaccines 2021;6:104.
7. Available from: <a href="https://www.saglik.gov.tr/TR,78148/ilk-koronavirus-asisi-saglik-bakani-fahrettin-kocaya-yapildi.html">https://www.saglik.gov.tr/TR,78148/ilk-koronavirus-asisi-saglik-bakani-fahrettin-kocaya-yapildi.html</a>[Accessed November1, 2022].
8. World Health Organization (WHO). The sinovac-CoronaVac COVID-19 vaccine: What you need to know (Updated June 10, 2022). Available from:<a href="%20https:/www.who.int/news-room/feature-stories/detail/the-sinovac-covid-19-vaccine-what-you-need-to"> https://www.who.int/news-room/feature-stories/detail</a>[Accessed October 3, 2022].
9. Abbott ARCHITECT SARS-CoV-2 IgG II Quant Reagent Instructions for Use. April 2021.
10. Altmann DM, Boyton RJ. COVID-19 vaccination: The road ahead. Science 2022;375:1127-32.
11. Kaya Ş, Yıldırım MS, Kavak Ş, et al. Sağlıkpersonelinde COVID-19 aşısısonrası spike antikord&uuml;zeyleri ne durumda?. TJCL 2022;13:260-2.
12. Yigit M, Ozkaya-Parlakay A, Cosgun Y, Ince YE, Bulut YE, Senel E. Should a third booster dose be scheduled after two doses of CoronaVac? A single-center experience. J Med Virol 2022;94:287-90.
13. ŞenolAkar Ş, Ak&ccedil;alı S, &Ouml;zkaya Y, et al. Sağlık&ccedil;alışanlarındainaktif SARS-CoV-2 aşılamasısonrasıyanetkiler, serokonversiyonoranlarıveantikoryanıtınıetkileyenfakt&ouml;rler [Factors affecting side effects, seroconversion rates and antibody response after inactivated SARS-CoV-2 vaccination in healthcare workers]. MikrobiyolBul 2021;55:519-38.
14. Vural S, Hacıbekiroğlu M, Yıldız FR, Vural P. Pandemide COVID-19 ge&ccedil;irmişvege&ccedil;irmemişbirgrupsağlık&ccedil;alışanındaaşısonrasıgelişenimm&uuml;nolojikcevap. ANKEM Derg 2021;35:45-52.
15. Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K. Causes, consequences, and reversal of immune system aging. J Clin Invest 2013;123:958-65.
16. World Health Organization (WHO). A healthy lifestyle - WHO recommendations (Updated May6, 2020). Available from:<a href="https://www.who.int/europe/news-room/fact-sheets/">https://www.who.int/europe/news-room/fact-sheets/</a>[Accessed October 4, 2022].
17. Mart&iacute; A, Marcos A, Mart&iacute;nez JA. Obesity and immune function relationships. Obes Rev 2001;2:131-40.
18. DemirTekol S, Altıntaş MM, Yılmaz E, Saracoğlu K, Demirhan R. Detection and evaluation of antibodies to SARS CoV-2 spike protein in healthcare workers after inactivated COVID-19 (CoronaVac) vaccination. SouthClinIstEuras 2021;32:217-22.
19. Pellini R, Venuti A, Pimpinelli F, et al. Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine. EClinicalMedicine 2021;36:100928.
20. Ferrara P, Gianfredi V, Tomaselli V, Polosa R. The effect of smoking on humoral response to COVID-19 vaccines: A systematic review of epidemiological studies. Vaccines (Basel) 2022;10:303.
21. Dundar B, Karahangil K, Elgormus CS, Topsakal HNH. Efficacy of antibody response following the vaccination of SARS-CoV-2 infected and noninfected healthcare workers by two-dose inactive vaccine against COVID-19. J Med Virol 2022;94:2431-7.
22. Ali H, Alahmad B, Al-Shammari AA, et al. Previous COVID-19 infection and antibody levels after vaccination. Front Public Health 2021;9:778243.
23. Bayram A, Demirbakan H, G&uuml;nelKaradeniz P, Erdoğan M, Ko&ccedil;er I. Quantitation of antibodies against SARS-CoV-2 spike protein after two doses of CoronaVac in healthcare workers. J Med Virol 2021;93:5560-7.
24. Fonseca MHG, de Souza TFG, de CarvalhoAra&uacute;jo FM, de Andrade LOM. Dynamics of antibody response toCoronaVac vaccine. J Med Virol 2022;94:2139-48.
25. Westhoff CM. The structure and function of the Rh antigen complex. SeminHematol 2007;44:42-50.
26. Kim Y, Latz CA, DeCarlo CS, et al. Relationship between blood type and outcomes following COVID-19 infection. SeminVascSurg 2021;34:125-31.
27. Bordino V, Vicentini C, Zotti CM. Response to &#39;Unlikely influence of ABO blood group polymorphism on antibody response to COVID-19 mRNA vaccine against SARS-CoV-2 spike protein&#39;. Vox Sang 2022;117:1128.
28. Greco M, Cucci F, Portulano P, et al. Effects of influenza vaccination on the response to BNT162b2 messenger RNA COVID-19 vaccine in healthcare workers. J Clin Med Res 2021;13:549-55.
29. Candelli M, Pignataro G, Torelli E, et al. Effect of influenza vaccine on COVID-19 mortality: a retrospective study.Intern Emerg Med<em></em>2021;16:1849-55.
Article available in :
Volume 2, Issue 4, 2022
Page : 123-126
https://doi.org/10.51271/KMJ-0085
Article Information
Received : 05 Eki 2022
Accepted : 15 Kas 2022
Published : 29 Ara 2022
Corresponding Author :

Enis Fuat Tüfekci: Kastamonu University, Faculty of Medicine, Department of Medical Microbiology, Kastamonu, Türkiye

[email protected]
Citation : Kılınç Ç, Yaşar Duman M, Çalışır B, Çöplü N, Özbek R, Demir C, Ergül Z, Tüfekci EF. Evaluation of anti-spike igg response after inactivated covid-19 vaccine in healthcare workers. Kastamonu Med J. 2022;2(4): 123-126.

Read: 159
Cited: 0
Download : 190
_Footer